v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Statement of Cash Flows [Abstract]    
Net loss $ (6,989,552) $ (3,572,285)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Stock based compensation expenses 156,813 235,497
Amortization and depreciation 398,106 18,319
Provision for expected credit losses 4,503,743 236,770
Change in value of derivative liabilities (1,184,221)
Amortization of debt discount 671,272
Gain on disposal of equipment 31
Change in operating assets and liabilities:    
Decrease (increase) in accounts receivable, net 267,149 (4,610,390)
(Increase) decrease in prepayment and deposit (40,548) 1,531,103
Decrease (increase) in others receivable 70,433 (425,360)
(Increase) decrease in inventories (62,357) 15,187
Increase in accounts payable 120,272 3,278,687
(Decrease) increase in accrual and other payables (1,423,163) 209,687
Increase (decrease) due to lease liability 21,774 (3,495)
Net Cash used in operating activities (3,490,279) (3,086,249)
Cash flows from investing activities    
Purchase of equipment (39,505) (1,826)
Net cash (used in) investing activities (39,505) (1,826)
Cash flows from financing activities    
Repayment of loan payable (751,122)
Proceeds from convertible promissory note 5,600,000
Proceeds from issuance of common stock 2,956,615
Net cash provided by financing activities 5,600,000 2,205,493
Effect of exchange rates on cash and cash equivalents (2,987) (23,717)
Net change in cash 2,067,229 (906,299)
Cash at beginning of period 68,596 1,128,135
Cash and restricted cash at end of period 2,135,825 221,836
Supplemental disclosures of cash flow information:    
Interest paid 735,180 92,129
Supplemental disclosures of non-cash investing and financing activities:    
Shares issued for conversion of convertible debt 2,065,567
Common stock issued for professional service 56,763
Conversion of customer deposit to shares 1,400,000
Common stock issued for acquisition of 9.9% equity interest of Lyken $ 500,000